Deletion of Glutamate Delta 1 Receptor Leads to Heterogeneous Transcription and Synaptic Gene Alterations Across Brain Regions.

Scientists studied a brain protein called GluD1 in mice by removing it and seeing what genes changed. They found that removing this protein affected different brain areas in different ways, but all changes were related to how brain cells communicate with each other. The affected genes are linked to intellectual disability and autism, suggesting this protein might be important in these conditions.

This preclinical study examined the molecular effects of deleting the glutamate delta 1 receptor (GluD1) in mouse brains using transcriptomics analysis. Researchers found that GluD1 deletion caused distinct gene expression changes across four brain regions (cortex, cerebellum, hippocampus, and striatum) and within hippocampal subregions. Despite regional differences, all affected genes were significantly enriched in synaptic signaling pathways, emphasizing GluD1's role in synaptic function. The study established connections between GluD1's interaction network and genes associated with intellectual disability and autism spectrum disorders, providing molecular evidence for GluD1's involvement in neurodevelopmental conditions.

This research provides molecular insights into how GluD1 dysfunction might contribute to autism and intellectual disability through disrupted synaptic signaling. While preliminary, these findings could inform future therapeutic targets and help understand the biological mechanisms underlying these neurodevelopmental conditions.

This is a preclinical mouse study, so findings may not translate directly to humans. Sample size is not reported. The study focuses on gene expression changes but does not demonstrate functional or behavioral outcomes.

Glutamate delta 1 receptor (GluD1) has various functional roles in the brain, such as high-frequency hearing, synapse formation and maintenance, and regulation of cognition disorders and neurodevelopmental disease. However, the underlying molecular mechanism, especially at the genetic level, remains to be elucidated. In this study, we use transcriptomics analysis to define the genetic impact of GluD1 across the brain regions in GluD1 knockout mice. Our results show that GluD1 deletion induced pronounced differences in gene expression both across the four brain regions (cortex, cerebellum, hippocampus, and striatum) and the distinct hippocampal subregions.

Despite differences in transcriptional profiles, the differentially expressed genes (DEGs) across all four brain regions show significant enrichment in synaptic signaling pathways, highlighting the critical role of GluD1 in synaptic function. The GluD1 interaction network and its downstream target genes are closely linked to the pathogenesis of intellectual disability (ID) and autism spectrum disorders (ASDs). In conclusion, our work reveals that GluD1 deletion leads to brain-region-specific transcriptional changes and establishes a genetic link between the interaction network with GluD1 and the risk genes for ID and ASD.